Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 35.2B | 39.2B | 34.8B | 38.8B |
Cost of revenue | 32.5B | 37.0B | 32.8B | 35.4B |
Gross profit | 2.7B | 2.3B | 2.0B | 3.4B |
Operating expense | ||||
Research & development | 132.2M | 257.3M | 161.2M | 153.7M |
Selling general and admin | 374.6M | 334.0M | 589.3M | 212.0M |
Other operating expenses | 262.7M | 368.2M | 273.3M | 429.9M |
Operating income | 2.0B | 1.0B | 1.1B | 2.5B |
Non operating interest income | ||||
Income | 27.3M | 26.6M | 40.8M | 46.1M |
Expense | 186.8M | 187.2M | 181.1M | 236.8M |
Other income expense | — | — | — | — |
Pretax income | 1.9B | 452.6M | 1.3B | 2.0B |
Tax provision | 508.4M | 199.9M | 489.2M | 579.2M |
Net income | 1.3B | 252.6M | 768.2M | 1.4B |
Basic EPS | 0.1 | — | — | — |
Diluted EPS | 0.1 | — | — | — |
Basic average shares | 12.5B | — | — | — |
Diluted average shares | 12.5B | — | — | — |
EBITDA | 2.1B | 979.9M | 1.3B | 2.5B |
Net income from continuing op. | — | — | — | — |
Minority interests | -213.0M | -174.0M | -219.6M | -334.6M |
Preferred stock dividends | 0 | 0 | 0 | 0 |